The World Health Organization (WHO) actively responds to anthrax epidemic in the Democratic Republic of the Congo (DRC) ...

The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...

We have identified an optimized peptide inhibitor that can be used to develop potent anthrax toxin therapeutics. Anthrax toxin, an essential virulence factor of Bacillus anthracis, elicits many of the ...

Prompt diagnosis and treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML), is very important because people with APL can quickly develop life-threatening ...

The county is responding to a potential anthrax outbreak in Gatanga Constituency, after over 600 residents ate meat from a ...

Blujepa: Most recently, the U.S. Food and Drug Administration (FDA) approved Blujepa (gepotidacin), the first of a new class of drugs for the treatment of uncomplicated urinary tract infections caused ...

FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections By Joseph Walker and ...

EP: 11. Other Investigational Treatment Options for SMA EP: 12. Insurance Considerations for SMA Therapies EP: 13. Optimizing Multidisciplinary Care Approaches for the Future of SMA Management EP: 14.

Girl, 4, Who Was Nearly Deported Despite Getting Life-Saving Medical Treatment, Has Been Granted Permission to Stay The girl was allowed in the U.S. "for life-saving treatment," her lawyers tell ...

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his allies may be in position to do something about it.

House Republicans’ Medicaid cuts would lead to coverage losses for more than 1.6 million Medicaid enrollees with substance-use disorder, reducing their access to treatment.